These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7482504)

  • 21. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
    Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
    Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
    Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
    Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
    Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of soluble and membrane bound HLA-class I and DR levels in umbilical cord blood and adult peripheral blood.
    Higuchi A; Hagihara M; Tsumuraya N; Gansuvd B; Kato S; Hotta T
    Tokai J Exp Clin Med; 2003 Apr; 28(1):1-7. PubMed ID: 12880297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble HLA levels in early pregnancy after in vitro fertilization.
    Pfeiffer KA; Rebmann V; Pässler M; van der Ven K; van der Ven H; Krebs D; Grosse-Wilde H
    Hum Immunol; 2000 Jun; 61(6):559-64. PubMed ID: 10825584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble HLA-II expression in African-Americans.
    Adamashvili I; Fraser PA; Milford EL; Sittig K; Gebel H; Zibari G; Pressly T; McDonald JC
    Inflamm Res; 2002 Jun; 51(6):290-4. PubMed ID: 12088269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance.
    Minguela A; Torío A; Marín L; Muro M; Villar LM; Díaz J; Ramírez P; Parrilla P; García-Alonso AM; Alvarez-López MR
    Hum Immunol; 1999 Jun; 60(6):500-9. PubMed ID: 10408799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome.
    Tolva J; Paakkanen R; Jarva H; Pussinen P; Havulinna AS; Salomaa V; Sinisalo J; Lokki ML
    Atherosclerosis; 2017 Nov; 266():58-63. PubMed ID: 28982023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum soluble HLA-DR antigens in autoimmune hepatitis.
    Hagihara M; Hosoi K; Kagawa T; Gansuvd B; Munkhbat B; Shimura T; Watanabe N; Matsuzaki S; Tsuji K
    Autoimmunity; 1999 Oct; 31(2):85-93. PubMed ID: 10680746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection.
    Ting YT; Coates PT; Marti HP; Dunn AC; Parker RM; Pickering JW; Jack RW; Kemp RA; Walker RJ; McLellan AD
    Transplantation; 2010 May; 89(9):1071-8. PubMed ID: 20098353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
    Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
    Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
    Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of the association between HLA phenotype and serum concentration of soluble HLA class I].
    Matsuura H; Jimbo S; Miyamura M; Katano M; Togashi K; Matsuda J
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):102-7. PubMed ID: 9178967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation.
    Steinhoff G; Wonigeit K; Pichlmayr R
    Transplantation; 1988 Feb; 45(2):394-401. PubMed ID: 2830687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble HLA-G in rheumatoid arthritis.
    Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
    Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.
    Le Maux A; Noël G; Birebent B; Grosset JM; Vu N; De Guibert S; Bernard M; Semana G; Amiot L
    Clin Exp Immunol; 2008 Apr; 152(1):50-6. PubMed ID: 18241225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
    Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
    Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
    Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.